Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Arzneimittel-Forschung
|
August 1, 1974
[Therapy of endogenous depression by sleep deprivation. 2. Comparison of psychopathologic and biochemical parameters]
P Loosen, M Ackenheil, D Athen, et al.
Pharmakopsychiatrie, Neuro-Psychopharmakologie
|
March 1, 1974
Catecholamine metabolism under sleep deprivation therapy of improved and not improved depressed patients. Contributions to biochemistry
N Matussek, M Ackenheil, D Athen, et al.
Nuklearmedizin. Nuclear Medicine
|
December 29, 2000
[Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease]
P Bartenstein, F Grünwald, T Kuwert, et al.
Arzneimittel-Forschung
|
January 1, 1976
[Comparison of the effects of the anthracene derivative danitracen (WA335-BS) and amitriptyline in depressive patients (author's transl)]
N Matussek, O Benkert, K Fidetzis, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1994
Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo
G B Cassano, C Toni, A Petracca, et al.
Psychopharmacology
|
July 31, 1998
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group
H Wetzel, G Gründer, A Hillert, et al.
Psychopharmacology
|
September 15, 1999
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic
G Gründer, M J Müller, J Andreas, et al.
Psychoneuroendocrinology
|
January 1, 1984
ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression
F Holsboer, O A Müller, H G Doerr, et al.
Pharmacopsychiatry
|
July 1, 1990
Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee
L Amaducci, J Angst, P Bech, et al.
Pharmacopsychiatry
|
October 7, 2004
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms
M J Müller, W Rossbach, K Mann, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Arzneimittel-Forschung
|
August 1, 1974
[Therapy of endogenous depression by sleep deprivation. 2. Comparison of psychopathologic and biochemical parameters]
P Loosen, M Ackenheil, D Athen, et al.
Pharmakopsychiatrie, Neuro-Psychopharmakologie
|
March 1, 1974
Catecholamine metabolism under sleep deprivation therapy of improved and not improved depressed patients. Contributions to biochemistry
N Matussek, M Ackenheil, D Athen, et al.
Nuklearmedizin. Nuclear Medicine
|
December 29, 2000
[Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease]
P Bartenstein, F Grünwald, T Kuwert, et al.
Arzneimittel-Forschung
|
January 1, 1976
[Comparison of the effects of the anthracene derivative danitracen (WA335-BS) and amitriptyline in depressive patients (author's transl)]
N Matussek, O Benkert, K Fidetzis, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1994
Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo
G B Cassano, C Toni, A Petracca, et al.
Psychopharmacology
|
July 31, 1998
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group
H Wetzel, G Gründer, A Hillert, et al.
Psychopharmacology
|
September 15, 1999
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic
G Gründer, M J Müller, J Andreas, et al.
Psychoneuroendocrinology
|
January 1, 1984
ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression
F Holsboer, O A Müller, H G Doerr, et al.
Pharmacopsychiatry
|
July 1, 1990
Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee
L Amaducci, J Angst, P Bech, et al.
Pharmacopsychiatry
|
October 7, 2004
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms
M J Müller, W Rossbach, K Mann, et al.
Page
of 18